Litcius/Paper detail

Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Wing‐Lok Chan, Cheuk‐Wai Choi, Yhi Wong, Terence Hon-Ting Tsang, Adrian Tin-Chung Lam, Rosa Pui-Ying Tse, Kelvin Chan, Claudia Wong, Betty Law, Emina Edith Cheung, Siu-Yin Chan, Ka-On Lam, Dora L.�W. Kwong, Simon Law

2022Annals of Surgical Oncology13 citationsDOI

Topics & Concepts

MedicineDocetaxelInduction chemotherapyEsophageal cancerHazard ratioSurgeryChemoradiotherapyRadical surgerySurgical oncologyInternal medicineOncologyChemotherapyConfidence intervalCancerEsophageal Cancer Research and TreatmentEsophageal and GI PathologyColorectal and Anal Carcinomas
Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma | Litcius